CLOSE X
GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
29.95 0.10(0.34%) NAV as on 07 Apr 2026
-3.32 % 1 M
7.42 % 1 Y
21.77 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.30

As on 28 Feb, 2026
age-icon Age :

6 yrs 8 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

854.04 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.62

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Others 1.55 %
Equity 98.45 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.34 %
Apollo Hospitals Enterprise Ltd.7.78 %
Torrent Pharmaceuticals Ltd.5.20 %
JB Chemicals & Pharmaceuticals...4.99 %
Ajanta Pharma Ltd.4.53 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs76.60
Hospital & Healthcare Services19.90
Business Support1.14
Chemicals0.81
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)18.2216.3626.4529.3930.19
Net Assets(Rs Crores) (as on 31-Mar-2026) 515.33 428.44 699.55 814.95 854.04
Scheme Returns(%)(Absolute)12.40-10.2661.3810.034.21
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7570/7611/9032/10220/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity29.950.10(0.34%)NAV As on 07 Apr, 202610-Jul-2019Inception Date854.04AUM In Cr.7.42%1Y21.77%3Y12.51%5Y17.65%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity36.69-0.01(-0.03%)NAV As on 07 Apr, 202613-Jul-2018Inception Date6,801.16AUM In Cr.6.69%1Y24.54%3Y15.50%5Y18.29%Since Inception
Nippon India Pharma Fund(G)Very HighEquity487.111.15(0.24%)NAV As on 07 Apr, 202605-Jun-2004Inception Date8,306.35AUM In Cr.7.00%1Y20.97%3Y13.46%5Y19.46%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors